Journal article
Mutation p.R356Q in the collybistin phosphoinositide binding site is associated with mild intellectual disability
Frontiers in Molecular Neuroscience, Vol.12, 60
2019
Abstract
The recruitment of inhibitory GABA-A receptors to neuronal synapses requires a complex interplay between receptors, neuroligins, the scaffolding protein gephyrin and the GDP-GTP exchange factor collybistin. Collybistin is regulated by protein-protein interactions at the N-terminal SH3 domain, which can bind neuroligins 2/4 and the GABA-AR α2 subunit. Collybistin also harbours a RhoGEF domain which mediates interactions with gephyrin and catalyses GDP-GTP exchange on Cdc42. Lastly, collybistin has a pleckstrin homology (PH) domain, which binds phosphoinositides, such as phosphatidylinositol 3-phosphate (PI3P/PtdIns3P) and phosphatidylinositol 4-monophosphate (PI4P /PtdIns4P). PI3P located in early/sorting endosomes has recently been shown to regulate the postsynaptic clustering of gephyrin and GABA-A receptors and consequently the strength of inhibitory synapses in cultured hippocampal neurons. This process is disrupted by mutations in the collybistin gene (ARHGEF9), which cause X-linked intellectual disability (XLID) by a variety of mechanisms converging on disrupted gephyrin and GABA-A receptor clustering at central synapses. Here we report a novel missense mutation (chrX:62875607C>T, p.R356Q) in ARHGEF9 that affects one of the two paired arginine residues in the PH domain that were predicted to be vital for binding phosphoinositides. Functional assays revealed that recombinant collybistin CB3SH3-R356Q was deficient in PI3P binding and was not able to translocate EGFP-gephyrin to submembrane microaggregates in an in vitro clustering assay. Expression of the PI3P-binding mutants CB3SH3-R356Q and CB3SH3-R356N/R357N in cultured hippocampal neurones revealed that the mutant proteins did not accumulate at inhibitory synapses, but instead resulted in a clear decrease in the overall number of synaptic gephyrin clusters compared to controls. Molecular dynamics simulations suggest that the p.R356Q substitution influences PI3P binding by altering the range of structural conformations adopted by collybistin. Taken together, these results suggest that the p.R356Q mutation in ARHGEF9 is the underlying cause of XLID in the probands, disrupting gephyrin clustering at inhibitory GABAergic synapses via loss of collybistin PH domain phosphoinositide binding.
Details
- Title
- Mutation p.R356Q in the collybistin phosphoinositide binding site is associated with mild intellectual disability
- Authors
- Tzu-Ting Chiou (Author) - University of Connecticut, United StatesPhilip Long (Author) - UCL School of Pharmacy, United KingdomAlexandra Schumann-Gillett (Author) - Australian National UniversityVenkateswarlu Kanamarlapudi (Author) - Swansea University, United KingdomStefan A Haas (Author) - Max Planck Institute for Molecular Genetics, GermanyKirsten Harvey (Author) - UCL School of Pharmacy, United KingdomMegan L O'Mara (Author) - Australian National UniversityAngel L De Blas (Author) - University of Connecticut, United StatesVera M Kalscheuer (Author) - Max Planck Institute for Molecular Genetics, GermanyRobert J Harvey (Author) - University of the Sunshine Coast - School of Health & Sports Sciences
- Publication details
- Frontiers in Molecular Neuroscience, Vol.12, 60; 13
- Publisher
- Frontiers Research Foundation
- Date published
- 2019
- DOI
- 10.3389/fnmol.2019.00060
- ISSN
- 1662-5099; 1662-5099
- Copyright note
- Copyright © 2019 Chiou, Long, Schumann-Gillett, Kanamarlapudi, Haas, Harvey, O'Mara, De Blas, Kalscheuer and Harvey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- Organisation Unit
- School of Health; University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy; Centre for Bioinnovation; School of Health and Behavioural Sciences - Legacy
- Language
- English
- Record Identifier
- 99450624902621
- Output Type
- Journal article
- Research Statement
- false
Metrics
7 File views/ downloads
252 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Neurosciences
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites